Albendazole is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mark Cuban Cost Plus Drug Company, Pbc. The primary component is Albendazole.
| Product ID | 78482-110_064c86bf-5d4d-4200-97fc-8ee09cabf000 |
| NDC | 78482-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Albendazole |
| Generic Name | Albendazole |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-08-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211117 |
| Labeler Name | Mark Cuban Cost Plus Drug Company, PBC |
| Substance Name | ALBENDAZOLE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-08-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0115-1701 | Albendazole | albendazole |
| 0591-2712 | Albendazole | Albendazole |
| 16714-907 | Albendazole | Albendazole |
| 31722-935 | Albendazole | Albendazole |
| 42291-093 | Albendazole | Albendazole |
| 42799-110 | Albendazole | Albendazole |
| 43598-452 | Albendazole | Albendazole |
| 51407-258 | Albendazole | Albendazole |
| 54505-055 | Albendazole | Albendazole |
| 62980-513 | Albendazole | Albendazole |
| 63629-1221 | Albendazole | Albendazole |
| 63629-9278 | Albendazole | Albendazole |
| 69097-237 | ALBENDAZOLE | albendazole |
| 69539-151 | Albendazole | Albendazole |
| 70710-1021 | Albendazole | Albendazole |
| 70771-1103 | Albendazole | Albendazole |
| 78482-110 | Albendazole | Albendazole |
| 52054-550 | ALBENZA | albendazole |
| 55695-021 | ALBENZA | albendazole |
| 64896-693 | ALBENZA | albendazole |
| 65084-462 | ALBENZA | albendazole |